InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by SAMAD SAM, Chief Financial Officer. Director active across 2 companies, notably Quest Diagnostics INC. In total, 10 reports have been logged. The latest transaction was disclosed on 20 April 2026 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
US$17,843108 shares@ US$165.21680.0001% mcap61.7% of flow
Common Stock
SEC:0001022079-26-000050·
€17,843108 shares@ €165.21680.0001% mcap30.8% of flow
Common Stock
SEC:0001022079-26-000050:0·
03,965 shares0
Common Stock
SEC:0001694295-26-000002·
03,965 shares0
Common Stock
SEC:0001694295-26-000002:0·
US$11,08468 shares@ US$162.99540.0001% mcap38.3% of flow
Common Stock
SEC:0001022079-25-000231·
€11,08468 shares@ €162.99540.0001% mcap19.2% of flow
Common Stock
SEC:0001022079-25-000231:0·
02,082 shares0
Common Stock
SEC:0001127602-22-008120:0·
04,561 shares0
Common Stock
SEC:0001127602-22-006629:0·
€255,367723 shares@ €353.20440.0012% mcap100.0% of flow
Common Stock
SEC:0001127602-21-028727·
€255,367723 shares@ €353.20440.0012% mcap50.0% of flow
Common Stock
SEC:0001127602-21-028727:0·
10 of 10 declarations
About SAMAD SAM
Sam Sam is Executive Vice President and Chief Financial Officer at Quest Diagnostics Inc. and Illumina, Inc. He is responsible for the financial management of these companies, including financial planning, performance analysis, and risk management. With a strong background in finance, he contributes to the growth and sustainability of the organizations.
